Cross-Trial Knowledge Transfer in Alzheimer’s Disease: A Machine Learning Approach Using the EXPEDITION Trials (S15.003)
To develop methods for enriching Alzheimer’s disease (AD) treatment trials with individuals likely to show clinically meaningful cognitive decline (CMCD) if treated with placebo.
Authors
- Richard B. Lipton (ORCID: https://orcid.org/0000-0003-2652-2897)
- Ali Ezzati (ORCID: https://orcid.org/0000-0003-1307-4589)
- Bhargav Teja Nallapu (ORCID: https://orcid.org/0000-0001-6368-8509)
- Babak Khorsand (ORCID: https://orcid.org/0000-0002-1585-3909)
- Elham Ghanbarian
Institutions
- Albert Einstein College of Medicine (US)
- University of California, Irvine (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208728
- Primary Topic
- Artificial Intelligence in Healthcare
- Type
- article
- Field-Weighted Citation Impact
- 0.00